[1]尚 滢.低剂量注射用甲泼尼龙琥珀酸钠治疗小儿脓毒血症的临床效果及对预后的影响[J].医学信息,2024,37(14):130-133.[doi:10.3969/j.issn.1006-1959.2024.14.026]
　SHANG Ying.Clinical Effect of Low-dose Methylprednisolone Sodium Succinate for Injection in the Treatment of Pediatric Sepsis and its Effect on Prognosis[J].Journal of Medical Information,2024,37(14):130-133.[doi:10.3969/j.issn.1006-1959.2024.14.026]
点击复制

低剂量注射用甲泼尼龙琥珀酸钠治疗小儿脓毒血症的临床效果及对预后的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年14期
页码:
130-133
栏目:
论著
出版日期:
2024-07-15

文章信息/Info

Title:
Clinical Effect of Low-dose Methylprednisolone Sodium Succinate for Injection in the Treatment of Pediatric Sepsis and its Effect on Prognosis
文章编号:
1006-1959（2024）14-0130-04
作者:
尚 滢
（天津市儿童医院重症医学科，天津 300134）
Author(s):
SHANG Ying
(Intensive Care Unit,Tianjin Children’s Hospital,Tianjin 300134,China)
关键词:
小儿脓毒血症; 注射用甲泼尼龙琥珀酸钠; 低剂量; 血清炎性因子; 血流动力学
Keywords:
pediatric sepsis; Methylprednisolone sodium succinate for injection; Low dose; Serum inflammatory factors; Hemodynamics
分类号:
R720.597
DOI:
10.3969/j.issn.1006-1959.2024.14.026
文献标志码:
A
摘要:
目的 研究低剂量注射用甲泼尼龙琥珀酸钠（MSSI）治疗小儿脓毒血症的临床效果及对其预后的影响。方法 选取2020年7月-2023年7月天津市儿童医院重症医学科收治的90例脓毒血症患儿，经随机数字表法分为对照组（45例）与观察组（45例），对照组行常规治疗，观察组在其基础上加用低剂量MSSI治疗，比较两组临床治疗效果[序贯器官衰竭估计（SOFA）]、血流动力学指标[心率（HR）、平均动脉压（MAP）]、血清炎性因子[降钙素原（PCT）]、预后情况（ICU住院时间、住院时间、休克发生率、28 d病死率）。结果 两组治疗后SOFA评分均低于治疗前，且观察组SOFA评分低于对照组（P＜0.05）。两组治疗后HR小于治疗前，MAP高于治疗前，且观察组HR小于对照组，MAP高于对照组（P＜0.05）。两组治疗后PCT低于治疗前，且观察组PCT低于对照组（P＜0.05）。观察组ICU住院时间、住院时间短于对照组（P＜0.05），休克发生率小于对照组（P＜0.05），两组28 d死亡率均为0。结论 低剂量MSSI对小儿脓毒血症具有确切治疗效果，可缓解病情，恢复患儿血流动力学水平，减轻其体内炎症，降低休克风险，加速预后康复。
Abstract:
Objective To study the clinical effect of low-dose methylprednisolone sodium succinate for injection (MSSI) in the treatment of pediatric sepsis and its effect on prognosis.Methods A total of 90 children with sepsis admitted to the Intensive Care Unit of Tianjin Children’s Hospital from July 2020 to July 2023 were selected and divided into control group (45 children) and observation group (45 children) by random number table method. The control group received routine treatment, and the observation group was treated with low-dose MSSI on the basis of the control group. The clinical treatment effects [sequential organ failure assessment (SOFA)], hemodynamic indexes [heart rate (HR), mean arterial pressure (MAP)], serum inflammatory factors [procalcitonin (PCT)], prognosis (ICU hospitalization time, hospitalization time, shock incidence, 28-day mortality) were compared between the two groups.Results After treatment, the SOFA scores of the two groups were lower than those before treatment, and the SOFA scores of the observation group were lower than those of the control group (P<0.05). After treatment, HR in the two groups was less than that before treatment, MAP was higher than that before treatment, and HR in the observation group was less than that in the control group, MAP was higher than that in the control group (P<0.05). After treatment, the PCT of the two groups were lower than those before treatment, and the PCT of the observation group were lower than those of the control group (P<0.05). The ICU hospitalization time and hospitalization time of the observation group were shorter than those of the control group (P<0.05), and the incidence of shock was lower than that of the control group (P<0.05). The 28-day mortality of the two groups was 0.Conclusion Low-dose MSSI has a definite therapeutic effect on sepsis in children, which can alleviate the condition, restore the hemodynamic level of children, reduce the inflammation in the body, reduce the risk of shock, and accelerate the recovery of prognosis.

参考文献/References:

[1]侯宇,敖雪,苏醒.不同病情严重程度脓毒症患者凝血功能的变化及对预后的影响[J].中国现代医学杂志,2023,33(22):70-75.[2]颜嘉怡,张静,王彬,等.血必净注射液静脉和口服给药防治脓毒症药效特点研究[J].药物评价研究,2023,46(11):2360-2365.[3]Soni S,Martens MD,Takahara S,et al.Exogenous ketone ester administration attenuates systemic inflammation and reduces organ damage in a lipopolysaccharide model of sepsis[J].Biochim Biophys Acta Mol Basis Dis,2022,1868(11):166507.[4]揭凤英,杨健,徐玲文,等.地塞米松联合促肾上腺皮质激素对脓毒症休克大鼠肾上腺皮质功能的研究[J].中国药师,2022,25(4):594-598.[5]王改,王巍伟,王雅卿,等.乌司他丁联合肾上腺皮质激素对脓毒症患儿肠黏膜屏障功能、NGAL、TREM-1水平的影响[J].河北医科大学学报,2021,42(8):920-925.[6]王鸿燕,赵月娥,林泽辉,等.参附注射液联合糖皮质激素治疗脓毒症的疗效观察[J].中国中医急症,2021,30(3):518-520.[7]曹钰,柴艳芬,邓颖,等.中国脓毒症/脓毒性休克急诊治疗指南(2018)[J].临床急诊杂志,2018,19(9):567-588.[8]Giustozzi M,Ehrlinder H,Bongiovanni D,et al.Coagulopathy and sepsis: Pathophysiology, clinical manifestations and treatment[J].Blood Rev,2021,50:100864.[9]林羽.连续性血液净化治疗对全身炎症反应综合征及脓毒血症患者一氧化氮合酶和降钙素原的影响分析[J].中国全科医学,2023,26(01):47-50.[10]Ye W,Liu X,Bai Y,et al.Sepsis Activates the TLR4/MyD88 Pathway in Schwann Cells to Promote Infiltration of Macrophages, Thereby Impeding Neuromuscular Function[J].Shock,2021,55(1):90-99.[11]陈东方,郑海,刘树峰,等.不同细菌感染引起的脓毒血症患者炎症因子水平[J].中华医院感染学杂志,2022,32(03):351-355.[12]揭凤英,徐玲文,董芳,等.糖皮质激素联合促肾上腺皮质激素对脓毒症休克大鼠肾上腺皮质功能的影响[J].微循环学杂志,2022,32(3):12-16.[13]薛骅,鲁丽利,向辉,等.乌司他丁联合氢化可的松治疗重症脓毒血症休克的疗效及对血清因子的影响[J].中国临床药理学与治疗学,2019,24(3):313-317.[14]Pastores SM.Steroids in the acutely ill: Evolving recommendations and practice[J].Cleve Clin J Med,2022,89(9):505-511.[15]Amano H,Kitagawa Y,Hayakawa T,et al.Methylprednisolone-induced anaphylaxis diagnosed by intradermal skin test: a case report[J].Allergy Asthma Clin Immunol,2021,17(1):70.[16]石晓娜,徐梅先,耿文锦,等.早期应用小剂量糖皮质激素治疗儿童脓毒性休克的效果及对免疫功能的影响[J].河北医药,2019,41(12):1770-1774.[17]陈嵩,诸海军,宋卫东,等.小剂量糖皮质激素对脓毒症休克患者免疫的影响[J].中国急救复苏与灾害医学杂志,2020,15(4):463-466.[18]张小明,蒲洁华.不同剂量甲泼尼龙对严重脓毒症患儿的免疫功能及炎症因子指标的影响分析[J].检验医学与临床,2020,17(19):2865-2867.[19]徐峰,扆鹏,高海晋,等.乌司他丁联合短程小剂量甲泼尼龙对脓毒症合并ARDS患者临床结局及炎症因子水平的影响[J].中华生物医学工程杂志,2022,28(2):189-193.[20]王娜.低剂量注射用甲泼尼龙琥珀酸钠联合CRRT疗法对脓毒血症患者免疫功能水平及预后的影响[J].河北医学,2019,25(6):922-927.[21]王翔,李建国,李志峰,等.参附注射液联合糖皮质激素对脓毒血症患者PCT、NT-proBNP及炎症因子的影响[J].中国中医急症,2019,28(6):954-957.

更新日期/Last Update: 1900-01-01